Citation | Ubigene

Application

Gene Editing Services

Ubigene has modified over 5000 genes from more than 200 cell lines with our exclusive innovation CRISPR-U™ technology. At the same time, we already provide customers with high quality gene-editing tools for cell or animal research worldwide.

Stable Cell Lines

Knockout Cell Lines

Knockin Cell Lines

Overexpression Cell Lines

Knockdown Cell Lines

iPSC and ESC Gene editing

Cloning Services

Knockout Plasmid

Point Mutation Plasmid

Knockin Plasmid

Overexpression Plasmid

Knockdown Plasmid

Virus Packaging

Lentivirus Packaging

Adenovirus Packaging

Adeno-associated Virus Packaging

CRISPR Library

Customized CRISPR Library

CRISPR Library In-stock

Microbe

Gene-editing E.coli

Gene-editing Salmonella

Gene-editing Pseudomonas aeruginosa

Cell Assay

Cell Proliferation

Cell Migration and Invasion

Cell Cycle

Cell Apoptosis

Detection of Marker Protein Expression

Cytokine Secretion and Enzyme Activity Test

Cytotoxicity Test

EZ-editor™
Gene-editing Series Products

With 12 years of experience, Ubigene has exclusively innovated and developed 6 product lines, fullfilling all kinds of needs from researchers. Experiment process simplified, efficiency improved, achieving our aim of 'Make genome editing easier'!

Red Cotton™ gRNA Plasmid Bank

Regular Plasmid

Lentiviral Plasmid

EZ-editor™ Culture Medium

Transfection Culture Medium

Cell Monoclonal Culture Medium

Knockout-cell-lysate

KO cell lysates (clone)

KO cell lysates (pool)

EZ-editor™ Cell Line

KO Cell Lines

Wild-type Cell Lines

Cas9 Stable Cell Lines

Luciferase Stable Cell Lines

EGFP Stable Cell Lines

EZ-editor™ Kits

Monoclone Validation Kit (extraction free)

EZ-editor™ Gene Knockout kit

Mouse Genotyping Kit

Lentiviral Packaging Kit

Lentivirus

IVD positive controls

Point Mutation gDNA/Cell Line

Red Cotton Gene knockout Project

Ubigene exclusive KO Cell Line Bank, over 5000 KO cell lines, covering thousands of genes from 8 popular signaling pathways and nearly 100 diseases.

Red Cotton CRISPR Gene Editing Designer

Gene Editing Cell Designer

Gene Editing Microbe Designer

Gene Editing Tool Kit

Red Cotton Gene knockout Project

Location：Home > Application >

Contact us✖

* Name：

Institution：

* Project Description：

* How would you like us to contact you?

* E-mail：

Phone：

WhatsAPP：

FaceBook Messenger：

Our Solution Specialists will contact you within 2 business days. Of course, you can also tell us when you would like to be contacted:

Select：

Source：

Other

Recommendations from others

How CRISPR helps to explore COVID-19 therapeutic targets？

This article shares some latest researches of COVID-19 utilizing gene-edited cells.Ubigene has developed a series of COVID-19 related cell products to help scientists to better carry out the basic research and drug R&D of SARS-CoV-2.
How can CRISPR facilitates Alzheimer's disease research?

Alzheimer's disease (AD) is a central neurodegenerative disease.For a long time, CRISPR has been evaluated as a valuable tool for the research of AD. Ubigene provides in-stock KO cell lines and gene knock-in and point mutation cell model construction services to meet various resea…
Latest researches of gene editing models in breast cancer

Up to now,there have plenty of publications about the research results of breast cancer using CRISPR technology，and here are some examples.Ubigene successfully constructed a Knockout Cell Line Bank with nearly 2000 genes which could help to facilitate the treatment of breast can…
[Research highlight] HAPLN1 promotes viability of RA-FLSs, disclosing the pathogenesis of RA

Yong Chen et al. from Shenzhen People's Hospital found that HAPLN1 accelerated the proliferation of RA-FLSs but inhibited its migration ability. Ubigene constructed HAPLN1 overexpression lentivirus for infection of RA-FLSs to help to study HAPLN1 network.
[Research highlight] Uncover the complex relationship between SNORD17 and p53 network in hepatocellul

This study reveals the regulatory role of small nucleolar RNA SNORD17 and p53 pathway in hepatocellular carcinoma, which provides a new potential target for the treatment of hepatocellular carcinoma.Ubigene provided SNORD17 knockout Hep G2 cell line in this study.